DK0948604T3 - Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet - Google Patents

Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet

Info

Publication number
DK0948604T3
DK0948604T3 DK97952333T DK97952333T DK0948604T3 DK 0948604 T3 DK0948604 T3 DK 0948604T3 DK 97952333 T DK97952333 T DK 97952333T DK 97952333 T DK97952333 T DK 97952333T DK 0948604 T3 DK0948604 T3 DK 0948604T3
Authority
DK
Denmark
Prior art keywords
bind
compounds
screening methods
features
pyk2 polypeptide
Prior art date
Application number
DK97952333T
Other languages
English (en)
Inventor
Joseph Schlessinger
Simma Lev
Original Assignee
Sugen Inc
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc, Univ New York filed Critical Sugen Inc
Application granted granted Critical
Publication of DK0948604T3 publication Critical patent/DK0948604T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Tires In General (AREA)
DK97952333T 1996-12-11 1997-12-09 Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet DK0948604T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3282496P 1996-12-11 1996-12-11
EP97952333A EP0948604B1 (en) 1996-12-11 1997-12-09 Screening methods for compounds binding to the Pyk2 polypeptide

Publications (1)

Publication Number Publication Date
DK0948604T3 true DK0948604T3 (da) 2004-11-22

Family

ID=21867009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952333T DK0948604T3 (da) 1996-12-11 1997-12-09 Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet

Country Status (11)

Country Link
US (2) US20020048782A1 (da)
EP (1) EP0948604B1 (da)
JP (1) JP2001505779A (da)
AT (1) ATE271603T1 (da)
AU (1) AU5596998A (da)
CA (1) CA2274805A1 (da)
DE (1) DE69729954T2 (da)
DK (1) DK0948604T3 (da)
ES (1) ES2227729T3 (da)
PT (1) PT948604E (da)
WO (1) WO1998026054A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
EP1630559A3 (en) * 1998-12-30 2006-06-07 Sugen, Inc. PYK2 (RAFTK) and inflammation
DE19860833C1 (de) * 1998-12-30 2000-09-07 Albrecht E Sippel Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen
AU2209899A (en) * 1998-12-30 2000-07-24 Sugen, Inc. Pyk2 (raftk) and inflammation
CA2362943A1 (en) * 1999-02-22 2000-08-24 Joseph Schlessinger Pyk2 binding proteins
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
EP1228766A1 (en) * 2001-01-31 2002-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. PYK2 phosphorylation by HER3 induces tumor invasion
DE10123055A1 (de) * 2001-05-11 2003-03-20 Gruenenthal Gmbh Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
DE10128541A1 (de) * 2001-06-13 2003-02-20 Gruenenthal Gmbh Screening-Verfahren mit BNPI und DNPI
WO2003053364A2 (en) * 2001-12-19 2003-07-03 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
US20040171062A1 (en) * 2002-02-28 2004-09-02 Plexxikon, Inc. Methods for the design of molecular scaffolds and ligands
RU2005107701A (ru) * 2002-09-19 2005-08-27 Пфайзер Продактс Инк. (Us) Индуцируемый клеточный анализ киназы фокальной адгезии
JP2007524374A (ja) * 2003-02-28 2007-08-30 プレキシコン,インコーポレーテッド Pyk2結晶構造および使用
US20050059621A1 (en) * 2003-06-06 2005-03-17 Irene Griswold-Prenner Methods for using modulators of proline-rich tyrosine kinase 2
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
AR056857A1 (es) 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
WO2009155060A2 (en) * 2008-05-28 2009-12-23 Mayo Foundation For Medical Education And Research Anti-pyk2 antibodies
BR112012012160B1 (pt) 2009-11-13 2022-04-26 Amgen, Inc. Material e métodos para tratar ou prevenir doenças associadas ao her-3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
DE3611194A1 (de) * 1986-04-04 1987-10-08 Bayer Ag Cancerostatisches mittel
DE3920029C2 (de) * 1988-06-30 1999-05-20 Clariant Finance Bvi Ltd Farbstoffe zum Färben von Kunststoffen
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
ES2227729T3 (es) 2005-04-01
EP0948604A2 (en) 1999-10-13
ATE271603T1 (de) 2004-08-15
JP2001505779A (ja) 2001-05-08
PT948604E (pt) 2004-10-29
WO1998026054A2 (en) 1998-06-18
US20030119067A1 (en) 2003-06-26
EP0948604B1 (en) 2004-07-21
DE69729954D1 (de) 2004-08-26
CA2274805A1 (en) 1998-06-18
WO1998026054A3 (en) 1998-09-03
US20020048782A1 (en) 2002-04-25
AU5596998A (en) 1998-07-03
DE69729954T2 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
WO1996018738A3 (en) PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
DE69635740D1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
DE69926731D1 (de) Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen
PT948604E (pt) Produtos e metodos relacionados com pyk2
DK0755446T3 (da) Cardiotrophin og anvendelser deraf
WO1998022589A3 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ATE313802T1 (de) Bestimmung von adrenomedullin-bindenden proteinen
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
ATE347561T1 (de) Behandlung von entzündungskrankheiten
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
DE69734890D1 (de) Rdgb-proteine
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
ATE317021T1 (de) Antisense modulierung von lfa-3
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
PE20399A1 (es) Muteina ob
DE59611293D1 (de) Protein mit dnase-aktivität
WO2004007536A3 (en) Interactions of the epstein-barr virus protein ebna1, and uses thereof
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
KR880701886A (ko) 췌장효소원의 유리활성화 펩티드의 면역검정에 의한 질병의 진단, 위중도 예견, 및 모니터링
NO20000345L (no) Humankloridionekanal-zsig44
WO2002088345A3 (en) Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
ATE104344T1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
ECSP972331A (es) Muteinas de la obesidad